StockData

OptimizeRx vs Outdoor

OPRX and POWW side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How OPRX and POWW compare

Outdoor is the larger company, worth 2.2 times as much as OptimizeRx ($290M against $131M).

On earnings, OptimizeRx is cheaper: it trades at 28.9× trailing earnings, against 83.3× for Outdoor.

Outdoor grew revenue faster over the last twelve months (9.7% versus −5.8% for OptimizeRx).

Outdoor keeps more of each dollar of sales as profit, with a net margin of 12.1% compared with 4.7% at OptimizeRx.

Outdoor scores higher on the StockData Score (11 against 10 for OptimizeRx), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricOPRXPOWW
Size and price
Market cap$131M$290M
Share price$6.94$2.50
Change, 1 year−54.3%39.7%
Change, 5 years−89.9%−60.0%
Beta (5Y)1.500.73
Employees10463
StockData Score
Total score1011 (better)
Valuation score3 (better)2
Growth score2 (better)1
Performance score22
Health score36 (better)
Dividend score00
Valuation
P/E28.9× (better)83.3×
P/S1.3× (better)5.4×
P/B1.0× (better)1.2×
EV/EBITDA8.3× (better)12.6×
P/FCF7.1× (better)30.9×
FCF yield14.0% (better)3.2%
Fair value$9.96$1.97
Margin of safety30.4% (better)−27.2%
Growth
Revenue growth (TTM)−5.8%9.7% (better)
Revenue growth, 5Y average20.4% (better)−3.9%
Profitability
Gross margin73.2%86.5% (better)
Operating margin11.1% (better)5.6%
Net margin4.7%12.1% (better)
FCF margin18.6% (better)17.5%
Return on equity3.7% (better)2.8%
Return on invested capital5.8% (better)1.5%
Financial health
Debt / equity0.15 (better)0.00
Net debt / EBITDA−0.33–
Interest coverage2.3×–
Current ratio5.58 (better)4.74
Altman Z-score2.825.52 (better)
Piotroski F-score8 (better)7
Dividends and buybacks
Buyback yield–0.07%
Shareholder yield0.00%0.07% (better)
Ownership
Held by institutions59.6%58.8%
Held by insiders19.4%43.9%
Insider net buying, 12 months−$18.8K–
Short interest, % of float7.8%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.